Skip to main content
NCBI home page
Medline Book to support NIHPA logoLink to Medline Book to support NIHPA
. 2022 Apr;26(21):1–158. doi: 10.3310/VHOH9034

Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCT.

Jonathan R Benger, Kim Kirby, Sarah Black, Stephen J Brett, Madeleine Clout, Michelle J Lazaroo, Jerry P Nolan, Barnaby C Reeves, Maria Robinson, Lauren J Scott, Helena Smartt, Adrian South, Elizabeth A Stokes, Jodi Taylor, Matthew Thomas, Sarah Voss, Sarah Wordsworth, Chris A Rogers
PMCID: PMC9082259  PMID: 35426781

Abstract

BACKGROUND

When a cardiac arrest occurs, cardiopulmonary resuscitation should be started immediately. However, there is limited evidence about the best approach to airway management during cardiac arrest.

OBJECTIVE

The objective was to determine whether or not the i-gel® (Intersurgical Ltd, Wokingham, UK) supraglottic airway is superior to tracheal intubation as the initial advanced airway management strategy in adults with non-traumatic out-of-hospital cardiac arrest.

DESIGN

This was a pragmatic, open, parallel, two-group, multicentre, cluster randomised controlled trial. A cost-effectiveness analysis accompanied the trial.

SETTING

The setting was four ambulance services in England.

PARTICIPANTS

Patients aged ≥ 18 years who had a non-traumatic out-of-hospital cardiac arrest and were attended by a participating paramedic were enrolled automatically under a waiver of consent between June 2015 and August 2017. Follow-up ended in February 2018.

INTERVENTION

Paramedics were randomised 1 : 1 to use tracheal intubation (764 paramedics) or i-gel (759 paramedics) for their initial advanced airway management and were unblinded.

MAIN OUTCOME MEASURES

The primary outcome was modified Rankin Scale score at hospital discharge or 30 days after out-of-hospital cardiac arrest, whichever occurred earlier, collected by assessors blinded to allocation. The modified Rankin Scale, a measure of neurological disability, was dichotomised: a score of 0-3 (good outcome) or 4-6 (poor outcome/death). The primary outcome for the economic evaluation was quality-adjusted life-years, estimated using the EuroQol-5 Dimensions, five-level version.

RESULTS

A total of 9296 patients (supraglottic airway group, 4886; tracheal intubation group, 4410) were enrolled [median age 73 years; 3373 (36.3%) women]; modified Rankin Scale score was known for 9289 patients. Characteristics were similar between groups. A total of 6.4% (311/4882) of patients in the supraglottic airway group and 6.8% (300/4407) of patients in the tracheal intubation group had a good outcome (adjusted difference in proportions of patients experiencing a good outcome: -0.6%, 95% confidence interval -1.6% to 0.4%). The supraglottic airway group had a higher initial ventilation success rate than the tracheal intubation group [87.4% (4255/4868) vs. 79.0% (3473/4397), respectively; adjusted difference in proportions of patients: 8.3%, 95% confidence interval 6.3% to 10.2%]; however, patients in the tracheal intubation group were less likely to receive advanced airway management than patients in the supraglottic airway group [77.6% (3419/4404) vs. 85.2% (4161/4883), respectively]. Regurgitation rate was similar between the groups [supraglottic airway group, 26.1% (1268/4865); tracheal intubation group, 24.5% (1072/4372); adjusted difference in proportions of patients: 1.4%, 95% confidence interval -0.6% to 3.4%], as was aspiration rate [supraglottic airway group, 15.1% (729/4824); tracheal intubation group, 14.9% (647/4337); adjusted difference in proportions of patients: 0.1%, 95% confidence interval -1.5% to 1.8%]. The longer-term outcomes were also similar between the groups (modified Rankin Scale: at 3 months, odds ratio 0.89, 95% confidence interval 0.69 to 1.14; at 6 months, odds ratio 0.91, 95% confidence interval 0.71 to 1.16). Sensitivity analyses did not alter the overall findings. There were no unexpected serious adverse events. Mean quality-adjusted life-years to 6 months were 0.03 in both groups (supraglottic airway group minus tracheal intubation group difference -0.0015, 95% confidence interval -0.0059 to 0.0028), and total costs were £157 (95% confidence interval -£270 to £583) lower in the tracheal intubation group. Although the point estimate of the incremental cost-effectiveness ratio suggested that tracheal intubation may be cost-effective, the huge uncertainty around this result indicates no evidence of a difference between groups.

LIMITATIONS

Limitations included imbalance in the number of patients in each group, caused by unequal distribution of high-enrolling paramedics; crossover between groups; and the fact that participating paramedics, who were volunteers, might not be representative of all paramedics in the UK. Findings may not be applicable to other countries.

CONCLUSION

Among patients with out-of-hospital cardiac arrest, randomisation to the supraglottic airway group compared with the tracheal intubation group did not result in a difference in outcome at 30 days. There were no notable differences in costs, outcomes and overall cost-effectiveness between the groups.

FUTURE WORK

Future work could compare alternative supraglottic airway types with tracheal intubation; include a randomised trial of bag mask ventilation versus supraglottic airways; and involve other patient populations, including children, people with trauma and people in hospital.

TRIAL REGISTRATION

This trial is registered as ISRCTN08256118.

FUNDING

This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and supported by the NIHR Comprehensive Research Networks and will be published in full in Health Technology Assessment; Vol. 26, No. 21. See the NIHR Journals Library website for further project information.

Plain language summary

BACKGROUND

Cardiac arrest is a serious medical emergency in which the heartbeat and breathing stop suddenly. Every year in the UK, a large number of patients (around 123 per 100,000) suffer a cardiac arrest outside hospital. Only 7–9% of these patients survive to leave hospital. The best initial treatment in cardiac arrest is cardiopulmonary resuscitation (commonly known as CPR), during which it is vital to give chest compressions and maintain a clear airway. Two main techniques are used to keep the airway clear: tracheal intubation (inserting a breathing tube into the windpipe) and a supraglottic airway device (a newer device that is inserted less deeply and sits just above the voicebox). Both techniques are used routinely by paramedics in the UK when treating a cardiac arrest, but there is no evidence about which technique is best. The AIRWAYS-2 trial aimed to find out whether or not a supraglottic airway device is better than tracheal intubation.

WHO PARTICIPATED AND WHAT WAS INVOLVED?

Paramedics from four UK ambulance services were put into one of two groups at random. One group was randomly chosen to use tracheal intubation and the other group was randomly chosen to use a supraglottic airway device at all adult cardiac arrests they attended for approximately 2 years. Paramedics were able to apply their clinical judgement and use a different device if they felt that this would be best for the patient. A total of 1523 paramedics took part and enrolled 9296 patients. Following cardiac arrest, a patient’s recovery was assessed as good or poor (including patients who did not survive).

WHAT DID THE TRIAL FIND?

A similar percentage of patients in both groups had a good recovery. There was no evidence to suggest that the supraglottic airway device was any better than tracheal intubation for treating a cardiac arrest.

Full text of this article can be found in Bookshelf.

References

  1. Taylor J, Black S, J Brett S, Kirby K, Nolan JP, Reeves BC, et al. Design and implementation of the AIRWAYS-2 trial: a multi-centre cluster randomised controlled trial of the clinical and cost effectiveness of the i-gel supraglottic airway device versus tracheal intubation in the initial airway management of out of hospital cardiac arrest. Resuscitation 2016;109:25–32. https://doi.org/10.1016/j.resuscitation.2016.09.016 doi: 10.1016/j.resuscitation.2016.09.016. [DOI] [PubMed]
  2. Woollard M. Public access defibrillation: a shocking idea? J Public Health Med 2001;23:98–102. https://doi.org/10.1093/pubmed/23.2.98 doi: 10.1093/pubmed/23.2.98. [DOI] [PubMed]
  3. Berdowski J, Berg RA, Tijssen JG, Koster RW. Global incidences of out-of-hospital cardiac arrest and survival rates: systematic review of 67 prospective studies. Resuscitation 2010;81:1479–87. https://doi.org/10.1016/j.resuscitation.2010.08.006 doi: 10.1016/j.resuscitation.2010.08.006. [DOI] [PubMed]
  4. NHS England. Ambulance Quality Indicators Data 2015–16. URL: www.england.nhs.uk/statistics/statistical-work-areas/ambulance-quality-indicators/ambulance-quality-indicators-data-2015-16/ (accessed 1 August 2018).
  5. Department of Health and Social Care. Ambulance Quality Indicators Data Downloads. URL: http://webarchive.nationalarchives.gov.uk/20130402162554/http://transparency.dh.gov.uk/2012/06/19/ambqidownloads/ (accessed 1 August 2018).
  6. London Ambulance Service NHS Trust. Cardiac Arrest Annual Report 2015/16. URL: www.emergency-live.com/wp-content/uploads/2017/03/Cardiac-Arrest-Annual-Report-2015-16-Final.pdf (accessed 5 June 2021).
  7. Gräsner JT, Lefering R, Koster RW, Masterson S, Böttiger BW, Herlitz J, et al. EuReCa ONE-27 Nations, ONE Europe, ONE Registry: a prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe. Resuscitation 2016;105:188–95. https://doi.org/10.1016/j.resuscitation.2016.06.004 doi: 10.1016/j.resuscitation.2016.06.004. [DOI] [PubMed]
  8. Lim C, Alexander MP, LaFleche G, Schnyer DM, Verfaellie M. The neurological and cognitive sequelae of cardiac arrest. Neurology 2004;63:1774–8. https://doi.org/10.1212/01.WNL.0000144189.83077.8E doi: 10.1212/01.WNL.0000144189.83077.8E. [DOI] [PubMed]
  9. van Alem AP, de Vos R, Schmand B, Koster RW. Cognitive impairment in survivors of out-of-hospital cardiac arrest. Am Heart J 2004;148:416–21. https://doi.org/10.1016/j.ahj.2004.01.031 doi: 10.1016/j.ahj.2004.01.031. [DOI] [PubMed]
  10. Becker LB, Aufderheide TP, Geocadin RG, Callaway CW, Lazar RM, Donnino MW, et al. Primary outcomes for resuscitation science studies: a consensus statement from the American Heart Association. Circulation 2011;124:2158–77. https://doi.org/10.1161/CIR.0b013e3182340239 doi: 10.1161/CIR.0b013e3182340239. [DOI] [PMC free article] [PubMed]
  11. Wang HE, Kupas DF, Paris PM, Bates RR, Yealy DM. Preliminary experience with a prospective, multi-centered evaluation of out-of-hospital endotracheal intubation. Resuscitation 2003;58:49–58. https://doi.org/10.1016/S0300-9572(03)00058-3 doi: 10.1016/S0300-9572(03)00058-3. [DOI] [PubMed]
  12. Nolan JP, Soar J. Airway techniques and ventilation strategies. Curr Opin Crit Care 2008;14:279–86. https://doi.org/10.1097/MCC.0b013e3282f85bc8 doi: 10.1097/MCC.0b013e3282f85bc8. [DOI] [PubMed]
  13. Wang HE, Simeone SJ, Weaver MD, Callaway CW. Interruptions in cardiopulmonary resuscitation from paramedic endotracheal intubation. Ann Emerg Med 2009;54:645–52.e1. https://doi.org/10.1016/j.annemergmed.2009.05.024 doi: 10.1016/j.annemergmed.2009.05.024. [DOI] [PubMed]
  14. Lyon RM, Ferris JD, Young DM, McKeown DW, Oglesby AJ, Robertson C. Field intubation of cardiac arrest patients: a dying art? Emerg Med J 2010;27:321–3. https://doi.org/10.1136/emj.2009.076737 doi: 10.1136/emj.2009.076737. [DOI] [PubMed]
  15. Kurola J, Harve H, Kettunen T, Laakso JP, Gorski J, Paakkonen H, Silfvast T. Airway management in cardiac arrest – comparison of the laryngeal tube, tracheal intubation and bag-valve mask ventilation in emergency medical training. Resuscitation 2004;61:149–53. https://doi.org/10.1016/j.resuscitation.2004.01.014 doi: 10.1016/j.resuscitation.2004.01.014. [DOI] [PubMed]
  16. Verghese C, Brimacombe JR. Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage. Anesth Analg 1996;82:129–33. https://doi.org/10.1097/00000539-199601000-00023 doi: 10.1097/00000539-199601000-00023. [DOI] [PubMed]
  17. Cook T, Howes B. Supraglottic airway devices: recent advances. Cont Ed Anaesth Crit Care Pain 2011;11:56–61. https://doi.org/10.1093/bjaceaccp/mkq058 doi: 10.1093/bjaceaccp/mkq058. [DOI]
  18. Nicholson A, Cook TM, Smith AF, Lewis SR, Reed SS. Supraglottic airway devices versus tracheal intubation for airway management during general anaesthesia in obese patients. Cochrane Database Syst Rev 2013;9:CD010105. https://doi.org/10.1002/14651858.CD010105.pub2 doi: 10.1002/14651858.CD010105.pub2. [DOI] [PMC free article] [PubMed]
  19. Soar J, Nolan JP. Airway management in cardiopulmonary resuscitation. Curr Opin Crit Care 2013;19:181–7. https://doi.org/10.1097/MCC.0b013e328360ac5e doi: 10.1097/MCC.0b013e328360ac5e. [DOI] [PubMed]
  20. Wang HE, Yealy DM. Managing the airway during cardiac arrest. JAMA 2013;309:285–6. https://doi.org/10.1001/jama.2012.216998 doi: 10.1001/jama.2012.216998. [DOI] [PubMed]
  21. Gazmuri RJ, Nolan JP, Nadkarni VM, Arntz HR, Billi JE, Bossaert L, et al. Scientific knowledge gaps and clinical research priorities for cardiopulmonary resuscitation and emergency cardiovascular care identified during the 2005 International Consensus Conference on ECC and CPR Science with Treatment Recommendations. A consensus statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Stroke Council; and the Cardiovascular Nursing Council. Resuscitation 2007;75:400–11. https://doi.org/10.1016/j.resuscitation.2007.09.008 doi: 10.1016/j.resuscitation.2007.09.008. [DOI] [PubMed]
  22. Kleinman ME, Perkins GD, Bhanji F, Billi JE, Bray JE, Callaway CW, et al. ILCOR scientific knowledge gaps and clinical research priorities for cardiopulmonary resuscitation and emergency cardiovascular care: a consensus statement. Resuscitation 2018;127:132–46. https://doi.org/10.1016/j.resuscitation.2018.03.021 doi: 10.1016/j.resuscitation.2018.03.021. [DOI] [PubMed]
  23. Nichol G, Brown SP, Perkins GD, Kim F, Sterz F, Broeckel Elrod JA, et al. What change in outcomes after cardiac arrest is necessary to change practice? Results of an international survey. Resuscitation 2016;107:115–20. https://doi.org/10.1016/j.resuscitation.2016.08.004 doi: 10.1016/j.resuscitation.2016.08.004. [DOI] [PubMed]
  24. Resuscitation Council UK. Resuscitation Guidelines. URL: www.resus.org.uk/resuscitation-guidelines/ (accessed 1 August 2018).
  25. Benger J, Coates D, Davies S, Greenwood R, Nolan J, Rhys M, et al. Randomised comparison of the effectiveness of the laryngeal mask airway supreme, i-gel and current practice in the initial airway management of out of hospital cardiac arrest: a feasibility study. Br J Anaesth 2016;116:262–8. https://doi.org/10.1093/bja/aev477 doi: 10.1093/bja/aev477. [DOI] [PubMed]
  26. Robinson MJ, Taylor J, Brett SJ, Nolan JP, Thomas M, Reeves BC, et al. Design and implementation of a large and complex trial in emergency medical services. Trials 2019;20:108. https://doi.org/10.1186/s13063-019-3203-0 doi: 10.1186/s13063-019-3203-0. [DOI] [PMC free article] [PubMed]
  27. Benger JR, Kirby K, Black S, Brett SJ, Clout M, Lazaroo MJ, et al. Effect of a strategy of a supraglottic airway device vs tracheal intubation during out-of-hospital cardiac arrest on functional outcome: the AIRWAYS-2 randomized clinical trial. JAMA 2018;320:779–91. https://doi.org/10.1001/jama.2018.11597 doi: 10.1001/jama.2018.11597. [DOI] [PMC free article] [PubMed]
  28. Association of Ambulance Chief Executives and Joint Royal Colleges Ambulance Liaison Committee. JRCALC Clinical Guidelines 2019. Bridgwater: Class Publishing; 2019.
  29. Duckett J, Fell P, Han K, Kimber C, Taylor C. Introduction of the I-gel supraglottic airway device for prehospital airway management in a UK ambulance service. Emerg Med J 2014;31:505–7. https://doi.org/10.1136/emermed-2012-202126 doi: 10.1136/emermed-2012-202126. [DOI] [PubMed]
  30. Häske D, Schempf B, Gaier G, Niederberger C. Performance of the i-gel™ during pre-hospital cardiopulmonary resuscitation. Resuscitation 2013;84:1229–32. https://doi.org/10.1016/j.resuscitation.2013.04.025 doi: 10.1016/j.resuscitation.2013.04.025. [DOI] [PubMed]
  31. Wang HE, Szydlo D, Stouffer JA, Lin S, Carlson JN, Vaillancourt C, et al. Endotracheal intubation versus supraglottic airway insertion in out-of-hospital cardiac arrest. Resuscitation 2012;83:1061–6. https://doi.org/10.1016/j.resuscitation.2012.05.018 doi: 10.1016/j.resuscitation.2012.05.018. [DOI] [PMC free article] [PubMed]
  32. Elliott VJ, Rodgers DL, Brett SJ. Systematic review of quality of life and other patient-centred outcomes after cardiac arrest survival. Resuscitation 2011;82:247–56. https://doi.org/10.1016/j.resuscitation.2010.10.030 doi: 10.1016/j.resuscitation.2010.10.030. [DOI] [PubMed]
  33. Rittenberger JC, Raina K, Holm MB, Kim YJ, Callaway CW. Association between Cerebral Performance Category, Modified Rankin Scale, and discharge disposition after cardiac arrest. Resuscitation 2011;82:1036–40. https://doi.org/10.1016/j.resuscitation.2011.03.034 doi: 10.1016/j.resuscitation.2011.03.034. [DOI] [PMC free article] [PubMed]
  34. Wissenberg M, Lippert FK, Folke F, Weeke P, Hansen CM, Christensen EF, et al. Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrest. JAMA 2013;310:1377–84. https://doi.org/10.1001/jama.2013.278483 doi: 10.1001/jama.2013.278483. [DOI] [PubMed]
  35. Hostler D, Everson-Stewart S, Rea TD, Stiell IG, Callaway CW, Kudenchuk PJ, et al. Effect of real-time feedback during cardiopulmonary resuscitation outside hospital: prospective, cluster-randomised trial. BMJ 2011;342:d512. https://doi.org/10.1136/bmj.d512 doi: 10.1136/bmj.d512. [DOI] [PMC free article] [PubMed]
  36. Christenson J, Andrusiek D, Everson-Stewart S, Kudenchuk P, Hostler D, Powell J, et al. Chest compression fraction determines survival in patients with out-of-hospital ventricular fibrillation. Circulation 2009;120:1241–7. https://doi.org/10.1161/CIRCULATIONAHA.109.852202 doi: 10.1161/CIRCULATIONAHA.109.852202. [DOI] [PMC free article] [PubMed]
  37. Lyon RM, Clarke S, Gowens P, Egan G, Clegg GR. Resuscitation quality assurance for out-of-hospital cardiac arrest – setting-up an ambulance defibrillator telemetry network. Resusc 2010;81:1726–8. https://doi.org/10.1016/j.resuscitation.2010.09.007 doi: 10.1016/j.resuscitation.2010.09.007. [DOI] [PubMed]
  38. European Medicines Agency (EMA). Guideline for Good Clinical Practice E6(R2). London: EMA; 2016. URL: https://s3.eu-west-2.amazonaws.com/www.hra.nhs.uk/media/documents/ema-gcp-guidance.pdf (accessed 22 April 2021).
  39. Benger JR, Voss S, Coates D, Greenwood R, Nolan J, Rawstorne S, et al. Randomised comparison of the effectiveness of the laryngeal mask airway supreme, i-gel and current practice in the initial airway management of prehospital cardiac arrest (REVIVE-Airways): a feasibility study research protocol. BMJ Open 2013;3:e002467. https://doi.org/10.1136/bmjopen-2012-002467 doi: 10.1136/bmjopen-2012-002467. [DOI] [PMC free article] [PubMed]
  40. Association of Ambulance Chief Executives. Measuring Patient Outcomes: Clinical Quality Indicators. URL: https://aace.org.uk/uk-ambulance-service/national-performance/ (accessed 24 July 2021).
  41. Department of Health and Social Care. Technical Guidance for the 2011/12 Operating Framework for the NHS. London: The Stationery Office; 2011. URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/216304/dh_123660.pdf (accessed 10 May 2021).
  42. Warwick Clinical Trials Unit. OHCAO: Project Overview. URL: https://warwick.ac.uk/fac/sci/med/research/ctu/trials/ohcao/overview/ (accessed 24 June 2018).
  43. Tagami T, Hirata K, Takeshige T, Matsui J, Takinami M, Satake M, et al. Implementation of the fifth link of the chain of survival concept for out-of-hospital cardiac arrest. Circulation 2012;126:589–97. https://doi.org/10.1161/CIRCULATIONAHA.111.086173 doi: 10.1161/CIRCULATIONAHA.111.086173. [DOI] [PubMed]
  44. Taljaard M, Weijer C, Grimshaw JM, Eccles MP, Ottawa Ethics of Cluster Randomised Trials Consensus Group. The Ottawa Statement on the ethical design and conduct of cluster randomised trials: precis for researchers and research ethics committees. BMJ 2013;346:f2838. https://doi.org/10.1136/bmj.f2838 doi: 10.1136/bmj.f2838. [DOI] [PubMed]
  45. Campbell MK, Elbourne DR, Altman DG, CONSORT group. CONSORT statement: extension to cluster randomised trials. BMJ 2004;328:702–8. https://doi.org/10.1136/bmj.328.7441.702 doi: 10.1136/bmj.328.7441.702. [DOI] [PMC free article] [PubMed]
  46. Perkins GD, Jacobs IG, Nadkarni VM, Berg RA, Bhanji F, Biarent D, et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update of the utstein resuscitation registry templates for out-of-hospital cardiac arrest: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia); and the American Heart Association Emergency Cardiovascular Care Committee and the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Resuscitation 2015;96:328–40. https://doi.org/10.1016/j.resuscitation.2014.11.002 doi: 10.1016/j.resuscitation.2014.11.002. [DOI] [PubMed]
  47. Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ 2018;27:7–22. https://doi.org/10.1002/hec.3564 doi: 10.1002/hec.3564. [DOI] [PMC free article] [PubMed]
  48. Smithson M, Verkuilen J. A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables. Psychol Methods 2006;11:54–71. https://doi.org/10.1037/1082-989X.11.1.54 doi: 10.1037/1082-989X.11.1.54. [DOI] [PubMed]
  49. Cameron AC, Gelbach JB, Miller DL. Bootstrap-based improvements for inference with clustered errors. Rev Econ Stat 2008;90:414–27. https://doi.org/10.1162/rest.90.3.414 doi: 10.1162/rest.90.3.414. [DOI]
  50. Hyslop T. SAS Macros for Bootstrap Samples with Stratification and Multiple Observations per Subject. URL: www.lexjansen.com/nesug/nesug95/NESUG95148.pdf (accessed 10 May 2021).
  51. Schomaker M, Heumann C. Bootstrap inference when using multiple imputation. Stat Med 2018;37:2252–66. https://doi.org/10.1002/sim.7654 doi: 10.1002/sim.7654. [DOI] [PMC free article] [PubMed]
  52. College of Paramedics Working Group. Consensus Statement. 2018. URL: www.collegeofparamedics.co.uk/COP/Professional_development/Intubation_Consensus_Statement_/COP/ProfessionalDevelopment/Intubation_Consensus_Statement_.aspx?hkey=5c999b6b-274b-42d3-8dbc-651c367c0493 (accessed 10 May 2021).
  53. Wang HE, Schmicker RH, Daya MR, Stephens SW, Idris AH, Carlson JN, et al. Effect of a strategy of initial laryngeal tube insertion vs. endotracheal intubation on 72-hour survival in adults with out-of-hospital cardiac arrest: a randomized clinical trial. JAMA 2018;320:769–78. https://doi.org/10.1001/jama.2018.7044 doi: 10.1001/jama.2018.7044. [DOI] [PMC free article] [PubMed]
  54. National Institute for Health and Care Excellence (NICE). Guide to the Methods of Technology Appraisal 2013. Process and Methods [PMG9]. London: NICE; 2013. [PubMed]
  55. EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health policy 1990;16:199–208. https://doi.org/10.1016/0168-8510(90)90421-9 doi: 10.1016/0168-8510(90)90421-9. [DOI] [PubMed]
  56. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727–36. https://doi.org/10.1007/s11136-011-9903-x doi: 10.1007/s11136-011-9903-x. [DOI] [PMC free article] [PubMed]
  57. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996;313:275–83. https://doi.org/10.1136/bmj.313.7052.275 doi: 10.1136/bmj.313.7052.275. [DOI] [PMC free article] [PubMed]
  58. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th edn. New York, NY: Oxford University Press; 2015.
  59. National Institute for Health and Care Excellence (NICE). Social Value Judgments: Principles for the Development of NICE Guidance. 2nd edn. London: NICE; 2008. [PubMed]
  60. NHS Supply Chain. National Catalogue. URL: https://my.supplychain.nhs.uk/Catalogue/browse/0/browsecatalogue (accessed 5 June 2021).
  61. NHS Employers. Agenda for Change Pay Scales and Points Poster 2017/18. URL: www.nhsemployers.org/case-studies-and-resources/2017/03/agenda-for-change-pay-scales-and-points-april-2017 (accessed 3 April 2018).
  62. Department of Health and Social Care (DHSC). NHS Reference Costs 2017/18. London: DHSC; 2018.
  63. Curtis L, Burns A. Unit Costs of Health and Social Care 2018. Canterbury: PSSRU, University of Kent; 2018.
  64. Curtis L, Burns A. Unit Costs of Health and Social Care 2017. Canterbury: PSSRU, University of Kent; 2017.
  65. Department of Health and Social Care (DHSC). NHS Reference Costs 2016/17. London: DHSC; 2017.
  66. Curtis L, Burns A. Unit Costs of Health and Social Care 2019. Canterbury: PSSRU, University of Kent; 2019.
  67. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095–108. https://doi.org/10.1097/00005650-199711000-00002 doi: 10.1097/00005650-199711000-00002. [DOI] [PubMed]
  68. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15. https://doi.org/10.1016/j.jval.2012.02.008 doi: 10.1016/j.jval.2012.02.008. [DOI] [PubMed]
  69. National Institute for Health and Care Excellence (NICE). Position Statement on Use of the EQ-5D-5L Value Set for England (Updated October 2019). URL: www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l (accessed 3 April 2020).
  70. Dritsaki M, Achana F, Mason J, Petrou S. Methodological issues surrounding the use of baseline health-related quality of life data to inform trial-based economic evaluations of interventions within emergency and critical care settings: a systematic literature review. PharmacoEconomics 2017;35:501–15. https://doi.org/10.1007/s40273-016-0485-x doi: 10.1007/s40273-016-0485-x. [DOI] [PubMed]
  71. Briggs A, Clark T, Wolstenholme J, Clarke P. Missing . . . presumed at random: cost-analysis of incomplete data. Health Econ 2003;12:377–92. https://doi.org/10.1002/hec.766 doi: 10.1002/hec.766. [DOI] [PubMed]
  72. Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. PharmacoEconomics 2014;32:1157–70. https://doi.org/10.1007/s40273-014-0193-3 doi: 10.1007/s40273-014-0193-3. [DOI] [PMC free article] [PubMed]
  73. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377–99. https://doi.org/10.1002/sim.4067 doi: 10.1002/sim.4067. [DOI] [PubMed]
  74. Carpenter JR, Goldstein H, Kenward MG. REALCOM-IMPUTE software for multilevel multiple imputation with mixed response types. J Stat Software 2011;45:14. https://doi.org/10.18637/jss.v045.i05 doi: 10.18637/jss.v045.i05. [DOI]
  75. Díaz-Ordaz K, Kenward MG, Grieve R. Handling missing values in cost effectiveness analyses that use data from cluster randomized trials. J Royal Stat Soc: Series A 2014;177:457–74. https://doi.org/10.1111/rssa.12016 doi: 10.1111/rssa.12016. [DOI]
  76. Gomes M, Díaz-Ordaz K, Grieve R, Kenward MG. Multiple imputation methods for handling missing data in cost-effectiveness analyses that use data from hierarchical studies: an application to cluster randomized trials. Med Decis Making 2013;33:1051–63. https://doi.org/10.1177/0272989X13492203 doi: 10.1177/0272989X13492203. [DOI] [PubMed]
  77. Rubin DB. Multiple Imputation for Non-response in Surveys. New York, NY: John Wiley & Sons, Inc.; 1987. https://doi.org/10.1002/9780470316696 doi: 10.1002/9780470316696. [DOI]
  78. Gomes M, Ng ES, Grieve R, Nixon R, Carpenter J, Thompson SG. Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials. Med Decision Making 2012;32:350–61. https://doi.org/10.1177/0272989X11418372 doi: 10.1177/0272989X11418372. [DOI] [PMC free article] [PubMed]
  79. Ng ES, Diaz-Ordaz K, Grieve R, Nixon RM, Thompson SG, Carpenter JR. Multilevel models for cost-effectiveness analyses that use cluster randomised trial data: an approach to model choice. Stat Methods Med Res 2016;25:2036–52. https://doi.org/10.1177/0962280213511719 doi: 10.1177/0962280213511719. [DOI] [PubMed]
  80. Her Majesty’s Government of the United Kingdom of Great Britain and Northern Ireland. Mental Health Act 2007. URL: www.legislation.gov.uk/ukpga/2007/12/contents (accessed 24 July 2021).
  81. Perkins GD, Lall R, Quinn T, Deakin CD, Cooke MW, Horton J, et al. Mechanical versus manual chest compression for out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised controlled trial. Lancet 2015;385:947–55. https://doi.org/10.1016/S0140-6736(14)61886-9 doi: 10.1016/S0140-6736(14)61886-9. [DOI] [PubMed]
  82. Great Britain. The Medicines for Human Use (Clinical Trials) Amendment (No.2) Regulations 2006. London: The Stationery Office; 2006.
  83. Lerner EB, Weik T, Edgerton EA. Research in prehospital care: overcoming the barriers to success. Prehosp Emerg Care 2016;20:448–53. https://doi.org/10.3109/10903127.2014.980480 doi: 10.3109/10903127.2014.980480. [DOI] [PubMed]
  84. Perkins GD, Ji C, Deakin CD, Quinn T, Nolan JP, Scomparin C, et al. A randomized trial of epinephrine in out-of-hospital cardiac arrest. N Engl J Med 2018;379:711–21. https://doi.org/10.1056/NEJMoa1806842 doi: 10.1056/NEJMoa1806842. [DOI] [PubMed]
  85. Jabre P, Penaloza A, Pinero D, Duchateau FX, Borron SW, Javaudin F, et al. Effect of bag-mask ventilation vs endotracheal intubation during cardiopulmonary resuscitation on neurological outcome after out-of-hospital cardiorespiratory arrest: a randomized clinical trial. JAMA 2018;319:779–87. https://doi.org/10.1001/jama.2018.0156 doi: 10.1001/jama.2018.0156. [DOI] [PMC free article] [PubMed]
  86. Higgs A, McGrath BA, Goddard C, Rangasami J, Suntharalingam G, Gale R, et al. Guidelines for the management of tracheal intubation in critically ill adults. Br J Anaesth 2018;120:323–52. https://doi.org/10.1016/j.bja.2017.10.021 doi: 10.1016/j.bja.2017.10.021. [DOI] [PubMed]
  87. Moorcraft SY, Marriott C, Peckitt C, Cunningham D, Chau I, Starling N, et al. Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey. Trials 2016;17:17. https://doi.org/10.1186/s13063-015-1105-3 doi: 10.1186/s13063-015-1105-3. [DOI] [PMC free article] [PubMed]
  88. The European Parliament and the Council of the European Union. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the Protection of Natural Persons with Regard to the Processing of Personal Data and on the Free Movement of Such Data, and Repealing Directive 95/46/EC (General Data Protection Regulation). URL: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R0679 (accessed 24 July 2021).
  89. NHS Digital. Data Security and Protection Toolkit. URL: https://digital.nhs.uk/data-and-information/looking-after-information/data-security-and-information-governance/data-security-and-protection-toolkit (accessed 24 July 2021).
  90. Andersen LW, Grossestreuer AV, Donnino MW. ‘Resuscitation time bias’ – a unique challenge for observational cardiac arrest research. Resuscitation 2018;125:79–82. https://doi.org/10.1016/j.resuscitation.2018.02.006 doi: 10.1016/j.resuscitation.2018.02.006. [DOI] [PMC free article] [PubMed]
  91. Carlson JN, Reynolds JC. Does advanced airway management improve outcomes in adult out-of-hospital cardiac arrest? Ann Emerg Med 2014;64:163–4. https://doi.org/10.1016/j.annemergmed.2013.12.003 doi: 10.1016/j.annemergmed.2013.12.003. [DOI] [PubMed]
  92. Swanson SA, Robins JM, Miller M, Hernán MA. Selecting on treatment: a pervasive form of bias in instrumental variable analyses. Am J Epidemiol 2015;181:191–7. https://doi.org/10.1093/aje/kwu284 doi: 10.1093/aje/kwu284. [DOI] [PMC free article] [PubMed]
  93. Hubble MW, Brown L, Wilfong DA, Hertelendy A, Benner RW, Richards ME. A meta-analysis of prehospital airway control techniques part I: orotracheal and nasotracheal intubation success rates. Prehosp Emerg Care 2010;14:377–401. https://doi.org/10.3109/10903121003790173 doi: 10.3109/10903121003790173. [DOI] [PubMed]
  94. Dyson K, Bray JE, Smith K, Bernard S, Straney L, Nair R, et al. Paramedic intubation experience is associated with successful tube placement but not cardiac arrest survival. Ann Emerg Med 2017;70:382–90.e1. https://doi.org/10.1016/j.annemergmed.2017.02.002 doi: 10.1016/j.annemergmed.2017.02.002. [DOI] [PubMed]
  95. Granfeldt A, Avis SR, Nicholson TC, Holmberg MJ, Moskowitz A, Coker A, et al. Advanced airway management during adult cardiac arrest: a systematic review. Resuscitation 2019;139:133–43. https://doi.org/10.1016/j.resuscitation.2019.04.003 doi: 10.1016/j.resuscitation.2019.04.003. [DOI] [PubMed]
  96. Soar J, Maconochie I, Wyckoff MH, Olasveengen TM, Singletary EM, Greif R, et al. 2019 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Resuscitation 2019;145:95–150. https://doi.org/10.1016/j.resuscitation.2019.10.016 doi: 10.1016/j.resuscitation.2019.10.016. [DOI] [PubMed]
  97. Haywood K, Whitehead L, Nadkarni VM, Achana F, Beesems S, Böttiger BW, et al. COSCA (Core Outcome Set for Cardiac Arrest) in adults: an advisory statement from the International Liaison Committee on Resuscitation. Circulation 2018;137:e783–e801. https://doi.org/10.1161/CIR.0000000000000562 doi: 10.1161/CIR.0000000000000562. [DOI] [PubMed]
  98. Smith K, Andrew E, Lijovic M, Nehme Z, Bernard S. Quality of life and functional outcomes 12 months after out-of-hospital cardiac arrest. Circulation 2015;131:174–81. https://doi.org/10.1161/CIRCULATIONAHA.114.011200 doi: 10.1161/CIRCULATIONAHA.114.011200. [DOI] [PubMed]
  99. Andrew E, Nehme Z, Wolfe R, Bernard S, Smith K. Long-term survival following out-of-hospital cardiac arrest. Heart 2017;103:1104–10. https://doi.org/10.1136/heartjnl-2016-310485 doi: 10.1136/heartjnl-2016-310485. [DOI] [PubMed]
  100. Lilja G, Nielsen N, Friberg H, Horn J, Kjaergaard J, Nilsson F, et al. Cognitive function in survivors of out-of-hospital cardiac arrest after target temperature management at 33°C versus 36°C. Circulation 2015;131:1340–9. https://doi.org/10.1161/CIRCULATIONAHA.114.014414 doi: 10.1161/CIRCULATIONAHA.114.014414. [DOI] [PubMed]
  101. Steinbusch CVM, van Heugten CM, Rasquin SMC, Verbunt JA, Moulaert VRM. Cognitive impairments and subjective cognitive complaints after survival of cardiac arrest: a prospective longitudinal cohort study. Resuscitation 2017;120:132–7. https://doi.org/10.1016/j.resuscitation.2017.08.007 doi: 10.1016/j.resuscitation.2017.08.007. [DOI] [PubMed]
  102. Tong JT, Eyngorn I, Mlynash M, Albers GW, Hirsch KG. Functional neurologic outcomes change over the first 6 months after cardiac arrest. Crit Care Med 2016;44:e1202–e1207. https://doi.org/10.1097/CCM.0000000000001963 doi: 10.1097/CCM.0000000000001963. [DOI] [PMC free article] [PubMed]
  103. Lim C, Verfaellie M, Schnyer D, Lafleche G, Alexander MP. Recovery, long-term cognitive outcome and quality of life following out-of-hospital cardiac arrest. J Rehabil Med 2014;46:691–7. https://doi.org/10.2340/16501977-1816 doi: 10.2340/16501977-1816. [DOI] [PMC free article] [PubMed]
  104. Arrich J, Zeiner A, Sterz F, Janata A, Uray T, Richling N, et al. Factors associated with a change in functional outcome between one month and six months after cardiac arrest: a retrospective cohort study. Resuscitation 2009;80:876–80. https://doi.org/10.1016/j.resuscitation.2009.04.045 doi: 10.1016/j.resuscitation.2009.04.045. [DOI] [PubMed]
  105. Stiell I, Nichol G, Wells G, De Maio V, Nesbitt L, Blackburn J, et al. Health-related quality of life is better for cardiac arrest survivors who received citizen cardiopulmonary resuscitation. Circulation 2003;108:1939–44. https://doi.org/10.1161/01.CIR.0000095028.95929.B0 doi: 10.1161/01.CIR.0000095028.95929.B0. [DOI] [PubMed]
  106. Stiell IG, Nesbitt LP, Nichol G, Maloney J, Dreyer J, Beaudoin T, et al. Comparison of the Cerebral Performance Category score and the Health Utilities Index for survivors of cardiac arrest. Ann Emerg Med 2009;53:241–8. https://doi.org/10.1016/j.annemergmed.2008.03.018 doi: 10.1016/j.annemergmed.2008.03.018. [DOI] [PubMed]
  107. Perkins GD, Quinn T, Deakin CD, Nolan JP, Lall R, Slowther AM, et al. Pre-hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC-2): trial protocol. Resuscitation 2016;108:75–81. https://doi.org/10.1016/j.resuscitation.2016.08.029 doi: 10.1016/j.resuscitation.2016.08.029. [DOI] [PMC free article] [PubMed]
  108. NHS Digital. HRG4+ 2017/18 Reference Costs Grouper. URL: https://digital.nhs.uk/services/national-casemix-office/downloads-groupers-and-tools/costing-hrg4-2017-18-reference-costs-grouper (accessed 24 July 2021).
  109. South Western Ambulance Service NHS Foundation Trust. Annual Report and Accounts 1 April 2018–31 March 2019. 2019. URL: www.england.nhs.uk/wp-content/uploads/2019/10/South_Western_Ambulance_Service_NHS_FT_Annual_Report_and_Accounts_2018-19.pdf (accessed 10 May 2021).
  110. Georghiou T, Bardsley M. Exploring the Cost of Care at the End of Life. London: Nuffield Trust; 2014.
  111. Curtis L, Burns A. Unit Costs of Health and Social Care 2015. Canterbury: PSSRU, University of Kent; 2015.

RESOURCES